Researchers
Dragoj, Miodrag
Results 41-60 of 116
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | Functional diagnostics as a new concept for the improvement of personalized targeted therapy | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2022 | A 3D Biomimetic System for Testing Anticancer Drug Sensitivity![]() | Dragoj, Miodrag | Book parts | 13 MNO za biologiju (24.04.2024.)M13 |
| 2022 | Development of a 3D Microenvironment for Engineering of Glioblastoma Brain Tumor![]() | Stojkovska, Jasmina | Conference Paper | Mp. category will be shown later |
| 2022 | Development of a 3D in vitro model based on alginate microfibers with immobilized cancer cells for cancer research and anticancer drug testing![]() | Petrović, Jelena | Conference Paper | Mp. category will be shown later |
| 2022 | Inhibicija autofagije senzitizuje ćelije glioblastoma na inhibitore Src tirozin-kinaze, derivate pirazolo[3,4-d]pirimidina Si306 i pro-Si306 | Jovanović Stojanov, Sofija | Conference Paper | Mp. category will be shown later |
| 2022 | On optimal temozolomide scheduling for slowly growing glioblastomas | Segura-Collar, Berta; Jiménez-Sánchez, Juan; Gargini, Ricardo; Dragoj, Miodrag | Article | 21M21 |
| 2022 | Anticancer effect of new carbonic anhydrase 9 inhibitors in glioblastoma cells | Jovanović, Mirna | Conference Paper | Mp. category will be shown later |
| 2022 | Anti-tumorski efekat inhibitora ugljenične anhidraze - derivata kumarina na ćelijama tumora pluća | Jovanović, Mirna | Conference Paper | Mp. category will be shown later |
| 2022 | A platform for reliable preclinical testing of anticancer drugs![]() | Stojkovska, Jasmina | Conference Paper | Mp. category will be shown later |
| 2022 | Decreased TSPAN14 Expression Contributes to NSCLC Progression | Jovanović, Mirna | Article | 21M21 |
| 2022 | Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells![]() | Divac Rankov, Aleksandra | Article | 21aM21a |
| 2022 | Development of 3D cancer cell culture models for anti-tumor drug testing![]() | Obradović, Bojana | Conference Paper | Mp. category will be shown later |
| 2022 | Ispitivanje matriksnih metaloproteinaza i fokalne adhezione kinaze kao farmakoloških meta kod nesitnoćelijskog karcinoma pluća | Jovanović-Stojanov, Sofija | Conference Paper | Mp. category will be shown later |
| 2022 | Multidrug-resistant cancer cells are sensitive to abietane diterpenoids from Plectranthus species | Jovanović, Mirna | Conference Paper | Mp. category will be shown later |
| 2022 | Autophagy inhibition sensitises glioblastoma cells to Src family kinase inhibitors Si306 and its prodrug![]() | Jovanović Stojanov, Sofija | Conference Paper | Mp. category will be shown later |
| 2021 | Analysis of alpha-1 antitrypsin expression in multidrug resistant cell lines![]() | Ljujić, Mila | Conference Paper | Mp. category will be shown later |
| 2021 | Sclareol, a natural compound, inhibits P-glycoprotein activity in cancer cells | Kostić, Ana | Conference Paper | Mp. category will be shown later |
| 2021 | Development of 3D microenvironment for engineering of glioblastoma brain tumor![]() | Stojkovska, Jasmina | Conference Paper | Mp. category will be shown later |
| 2021 | In vitro biomimetic models for glioblastoma-a promising tool for drug response studies | Stanković, Tijana; Ranđelović, Teodora; Dragoj, Miodrag | Article | 21a+M21a+ |
| 2021 | Novel anti-cancer compound – inibitor of TrxR distress GSH system in glioma cells | Jovanović, Mirna | Conference Paper | Mp. category will be shown later |

